Natural products and their derivatives as multifunctional ligands against Alzheimer's disease
- PMID: 31820476
- DOI: 10.1002/ddr.21587
Natural products and their derivatives as multifunctional ligands against Alzheimer's disease
Abstract
Alzheimer's disease (AD), a complex neurodegenerative disorder causing multiple cellular changes including impaired cholinergic system, beta-amyloid (βA) aggregation, tau hyperphosphorylation, metal dyshomeostasis, neuroinflammation, and many other pathways are involved in the pathogenesis of the disease. However, the exact cause of the disease is not known. Natural products such as flavonoids, alkaloids, resveratrol, and curcumin have multifunctional properties, and have drawn the attention of the researchers because these molecules are capable of interacting concurrently with the multiple targets of AD. Therefore, natural products and their derivatives with proven efficacy could be used in the management of the neurodegenerative disorders. This review focuses on the natural product based multitarget directed ligands like tacrine-coumarin, tacrine-huperzine A, harmine-isoxazoline, berberine-thiophenyl, galantamine-indole, pyridoxine-resveratrol, donepezil-curcumin and their mode of action.
Keywords: Alzheimer's; alkaloid; flavonoid; multitarget ligand.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
Management of oxidative stress and other pathologies in Alzheimer's disease.Arch Toxicol. 2019 Sep;93(9):2491-2513. doi: 10.1007/s00204-019-02538-y. Epub 2019 Aug 22. Arch Toxicol. 2019. PMID: 31440798 Review.
-
Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.J Ethnopharmacol. 2018 Apr 6;215:42-73. doi: 10.1016/j.jep.2017.12.015. Epub 2017 Dec 14. J Ethnopharmacol. 2018. PMID: 29248451 Review.
-
Tacrine-Natural-Product Hybrids for Alzheimer's Disease Therapy.Curr Med Chem. 2020;27(26):4392-4400. doi: 10.2174/0929867325666180403151725. Curr Med Chem. 2020. PMID: 29611473 Review.
-
Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer's Disease.Curr Med Chem. 2021;28(23):4799-4825. doi: 10.2174/0929867327666200730213215. Curr Med Chem. 2021. PMID: 32744957 Review.
-
Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.Future Med Chem. 2012 Sep;4(13):1751-61. doi: 10.4155/fmc.12.124. Future Med Chem. 2012. PMID: 22924511 Free PMC article. Review.
Cited by
-
Role of Cholinergic Signaling in Alzheimer's Disease.Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816. Molecules. 2022. PMID: 35335180 Free PMC article. Review.
-
Natural product-based pharmacological studies for neurological disorders.Front Pharmacol. 2022 Nov 7;13:1011740. doi: 10.3389/fphar.2022.1011740. eCollection 2022. Front Pharmacol. 2022. PMID: 36419628 Free PMC article. Review.
-
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease.Pharmaceutics. 2023 Sep 22;15(10):2369. doi: 10.3390/pharmaceutics15102369. Pharmaceutics. 2023. PMID: 37896129 Free PMC article.
-
Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.Int J Mol Sci. 2020 Mar 13;21(6):1975. doi: 10.3390/ijms21061975. Int J Mol Sci. 2020. PMID: 32183162 Free PMC article. Review.
-
Isoxazole/Isoxazoline Skeleton in the Structural Modification of Natural Products: A Review.Pharmaceuticals (Basel). 2023 Feb 2;16(2):228. doi: 10.3390/ph16020228. Pharmaceuticals (Basel). 2023. PMID: 37259376 Free PMC article. Review.
References
REFERENCE
-
- Ahmed, T., Enam, S., & Gilani, A. (2010). Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Neuroscience, 169(3), 1296-1306.
-
- Ahmed, T., & Gilani, A.-H. (2009). Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacology Biochemistry and Behavior, 91(4), 554-559.
-
- Ansari, N., & Khodagholi, F. (2013). Natural products as promising drug candidates for the treatment of Alzheimer's disease: Molecular mechanism aspect. Current Neuropharmacology, 11(4), 414-429.
-
- Association, A.S. (2017). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 13(4), 325-373.
-
- Atanasova, M., Stavrakov, G., Philipova, I., Zheleva, D., Yordanov, N., & Doytchinova, I. (2015). Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity. Biorganic and Medicinal Chemistry, 23(17), 5382-5389.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical